Potential treatment options and future research to increase hepatitis C virus treatment response rate

Hepatitis C virus (HCV) is a liver-tropic blood-borne pathogen that affects more than 170 million people worldwide. Although acute infections are usually asymptomatic, up to 90% of HCV infections persist with the possibility of long-term consequences such as liver fibrosis, cirrhosis, steatosis, ins...

Descripción completa

Detalles Bibliográficos
Autores principales: TenCate, Veronica, Sainz, Bruno, Cotler, Scott J, Uprichard, Susan L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039485/
https://www.ncbi.nlm.nih.gov/pubmed/21331152
http://dx.doi.org/10.2147/HMER.S7193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039485/
https://www.ncbi.nlm.nih.gov/pubmed/21331152
http://dx.doi.org/10.2147/HMER.S7193

Ejemplares similares